Immersive virtual reality as a competitive training strategy for the biopharma industry

Philip Wismer; Ainara Lopez Cordoba; Sarune Baceviciute; Frederik Clauson-Kaas; Morten Otto Alexander Sommer

doi:10.1038/s41587-020-00784-5

Immersive virtual reality as a competitive training strategy for the biopharma industry

Philip Wismer
, Ainara Lopez Cordoba
, Sarune Baceviciute
, Frederik Clauson-Kaas
, Morten Otto Alexander Sommer^*

^*Corresponding author for this work

University of Copenhagen
Labster ApS

Research output: Contribution to journal › Comment/debate › Research › peer-review

Original language	English
Journal	Nature Biotechnology
Volume	39
Issue number	1
Pages (from-to)	116-119
ISSN	1087-0156
DOIs	https://doi.org/10.1038/s41587-020-00784-5
Publication status	Published - Jan 2021

Bibliographical note

Funding Information:
The authors would like to thank our collaborators from the biopharma industry, A. Pittelkov, J. Scholl-Fleischer, S. Martinussen, J. N. Sørensen and F. Christensen, for providing reagents and equipment, co-creating the VR simulation and organizing the interventions at the production schools. We would like to acknowledge L. Dam Pedersen, K. Juul Thomson, M. Nielsen Gravholt and M. Lyhne Haslund for inviting us to conduct this study at their schools. Acknowledgements also to our metrology experts N. Vad Eiberg, H. Graulund and T. Bolt Botnen for training students in real life and assessing their practical skills. Great thanks to M. Mouritz Marfelt for initiating and negotiating the collaboration with the biopharma industry. Our thanks also go to S. Stauffer, A. Mortensen and E. Durand, who helped with instructing participants on how to use the VR headsets on the training days. We would like to acknowledge D. Franke, S. Tjong, H. Hansen and N. Dewa for their relentless effort creating the VR simulation. Finally, our thanks go to C. Tachibana for copyediting. The study was funded by Innovation Fund Denmark, large-scale project 5150-00033, SIPROS. M.O.A.S. further acknowledges funding from the Novo Nordisk Foundation under NFF grant number NNF10CC1016517.

Funding Information:
A.L.C. and F.C.-K. are employees of Labster ApS. P.W. and S.B. received funding from a joint grant between the University of Copenhagen, the Technical University of Denmark and Labster ApS, where they were formerly employed. P.W, A.L.C. and F.C.-K. hold warrants in Labster ApS according to the length of their employment.

Access to Document

10.1038/s41587-020-00784-5

OpenUrl availability

Check availability in DTU Findit

Cite this

@article{ab22dbdd0ed649e5b2d37b1f0dfb1a06,

title = "Immersive virtual reality as a competitive training strategy for the biopharma industry",

author = "Philip Wismer and \{Lopez Cordoba\}, Ainara and Sarune Baceviciute and Frederik Clauson-Kaas and Sommer, \{Morten Otto Alexander\}",

note = "Funding Information: The authors would like to thank our collaborators from the biopharma industry, A. Pittelkov, J. Scholl-Fleischer, S. Martinussen, J. N. S{\o}rensen and F. Christensen, for providing reagents and equipment, co-creating the VR simulation and organizing the interventions at the production schools. We would like to acknowledge L. Dam Pedersen, K. Juul Thomson, M. Nielsen Gravholt and M. Lyhne Haslund for inviting us to conduct this study at their schools. Acknowledgements also to our metrology experts N. Vad Eiberg, H. Graulund and T. Bolt Botnen for training students in real life and assessing their practical skills. Great thanks to M. Mouritz Marfelt for initiating and negotiating the collaboration with the biopharma industry. Our thanks also go to S. Stauffer, A. Mortensen and E. Durand, who helped with instructing participants on how to use the VR headsets on the training days. We would like to acknowledge D. Franke, S. Tjong, H. Hansen and N. Dewa for their relentless effort creating the VR simulation. Finally, our thanks go to C. Tachibana for copyediting. The study was funded by Innovation Fund Denmark, large-scale project 5150-00033, SIPROS. M.O.A.S. further acknowledges funding from the Novo Nordisk Foundation under NFF grant number NNF10CC1016517. Funding Information: A.L.C. and F.C.-K. are employees of Labster ApS. P.W. and S.B. received funding from a joint grant between the University of Copenhagen, the Technical University of Denmark and Labster ApS, where they were formerly employed. P.W, A.L.C. and F.C.-K. hold warrants in Labster ApS according to the length of their employment.",

year = "2021",

month = jan,

doi = "10.1038/s41587-020-00784-5",

language = "English",

volume = "39",

pages = "116--119",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Research",

number = "1",

}

TY - JOUR

T1 - Immersive virtual reality as a competitive training strategy for the biopharma industry

AU - Wismer, Philip

AU - Lopez Cordoba, Ainara

AU - Baceviciute, Sarune

AU - Clauson-Kaas, Frederik

AU - Sommer, Morten Otto Alexander

N1 - Funding Information: The authors would like to thank our collaborators from the biopharma industry, A. Pittelkov, J. Scholl-Fleischer, S. Martinussen, J. N. Sørensen and F. Christensen, for providing reagents and equipment, co-creating the VR simulation and organizing the interventions at the production schools. We would like to acknowledge L. Dam Pedersen, K. Juul Thomson, M. Nielsen Gravholt and M. Lyhne Haslund for inviting us to conduct this study at their schools. Acknowledgements also to our metrology experts N. Vad Eiberg, H. Graulund and T. Bolt Botnen for training students in real life and assessing their practical skills. Great thanks to M. Mouritz Marfelt for initiating and negotiating the collaboration with the biopharma industry. Our thanks also go to S. Stauffer, A. Mortensen and E. Durand, who helped with instructing participants on how to use the VR headsets on the training days. We would like to acknowledge D. Franke, S. Tjong, H. Hansen and N. Dewa for their relentless effort creating the VR simulation. Finally, our thanks go to C. Tachibana for copyediting. The study was funded by Innovation Fund Denmark, large-scale project 5150-00033, SIPROS. M.O.A.S. further acknowledges funding from the Novo Nordisk Foundation under NFF grant number NNF10CC1016517. Funding Information: A.L.C. and F.C.-K. are employees of Labster ApS. P.W. and S.B. received funding from a joint grant between the University of Copenhagen, the Technical University of Denmark and Labster ApS, where they were formerly employed. P.W, A.L.C. and F.C.-K. hold warrants in Labster ApS according to the length of their employment.

PY - 2021/1

Y1 - 2021/1

U2 - 10.1038/s41587-020-00784-5

DO - 10.1038/s41587-020-00784-5

M3 - Comment/debate

C2 - 33432226

AN - SCOPUS:85099101925

SN - 1087-0156

VL - 39

SP - 116

EP - 119

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 1

ER -